Cas 935277-35-3,tert-butyl 1-(3,5-difluorophenyl)-4-(1-(4,4-dimethylpentyl)-cyclopropylamino)-3-hydroxybutan-2-ylcarbamate

935277-35-3

Post Buying Request

Basic information

Product Name: tert-butyl 1-(3,5-difluorophenyl)-4-(1-(4,4-dimethylpentyl)-cyclopropylamino)-3-hydroxybutan-2-ylcarbamate
Synonyms: tert-butyl 1-(3,5-difluorophenyl)-4-(1-(4,4-dimethylpentyl)-cyclopropylamino)-3-hydroxybutan-2-ylcarbamate
CAS NO:935277-35-3
Molecular Formula:
Molecular Weight: 454.601
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: tert-butyl 1-(3,5-difluorophenyl)-4-(1-(4,4-dimethylpentyl)-cyclopropylamino)-3-hydroxybutan-2-ylcarbamate(CAS DataBase Reference)
NIST Chemistry Reference: tert-butyl 1-(3,5-difluorophenyl)-4-(1-(4,4-dimethylpentyl)-cyclopropylamino)-3-hydroxybutan-2-ylcarbamate(935277-35-3)
EPA Substance Registry System: tert-butyl 1-(3,5-difluorophenyl)-4-(1-(4,4-dimethylpentyl)-cyclopropylamino)-3-hydroxybutan-2-ylcarbamate(935277-35-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 935277-35-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

935277-35-3 Suppliers

Recommended suppliers

935277-35-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 935277-35-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,5,2,7 and 7 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 935277-35:
(8*9)+(7*3)+(6*5)+(5*2)+(4*7)+(3*7)+(2*3)+(1*5)=193
193 % 10 = 3
So 935277-35-3 is a valid CAS Registry Number.

935277-35-3Upstream product

935277-35-3Downstream Products

935277-35-3Relevant academic research and scientific papers

METHODS OF TREATING AMYLOIDOSIS USING CYCLOPROPYL DERIVATIVE ASPARTYL PROTEASE INHIBITORS

-

Page/Page column 65, (2010/11/27)

The invention relates to novel compounds and methods of treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta prote

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 935277-35-3